Erector Spinae Block in Management of Herpes Zoster Pai
Not Applicable
- Conditions
- Herpes Zoster
- Registration Number
- PACTR201905893503298
- Lead Sponsor
- Department of Anaesthesia and Surgical Intensive Care Faculty of Medicine University of Alexandria
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Moderate pain, Visual Analog Scale (VAS) = 4
less than 5 affected dermatomes.
thoracic eruption < 3 months.
Exclusion Criteria
ASA status IV, V.
coagulation abnormalities
known allergy to methylprednisolone or bupivacaine
serum creatinine = 5 mg/dL
Patients coming after = 3 months after rash healing.
chronic pain for any other reason requiring analgesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain relief
- Secondary Outcome Measures
Name Time Method post herpetic neuralgia;average dose of Pregabalin and Acetaminophen consumed<br>;serum interleukin-6